TrialFrontiers in immunology2020

Evaluation of T-Cell Responses Against Shared Melanoma Associated Antigens and Predicted Neoantigens in Cutaneous Melanoma Patients Treated With the CSF-470 Allogeneic Cell Vaccine Plus BCG and GM-CSF.

Enrique Podaza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.